Clinical Trials Logo

Genital Warts clinical trials

View clinical trials related to Genital Warts.

Filter by:

NCT ID: NCT00520598 Completed - Cervical Cancer Clinical Trials

Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)

Start date: October 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and immunogenicity of V505 in comparison to GARDASIL (TM)

NCT ID: NCT00517309 Completed - Cervical Cancer Clinical Trials

Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED)

FUTURE
Start date: December 28, 2001
Phase: Phase 3
Study type: Interventional

The primary purpose of the study is to test the safety of HPV Vaccine in Women

NCT ID: NCT00501137 Completed - Cervical Cancer Clinical Trials

A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine

BCGov-01
Start date: July 2007
Phase: Phase 3
Study type: Interventional

Primary objective is to determine if antibody responses to HPV types 16 & 18 are non-inferior after a 2-dose paediatric regimen as compared to a 3-dose adult regimen of Q-HPV vaccination, with responses measured at Month 7.

NCT ID: NCT00499967 Completed - Genital Warts Clinical Trials

Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts

Start date: August 2007
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety, tolerability and activity of GS-9191 ointment in the treatment of genital warts. GS-9191 ointment is intended for topical application directly to genital warts on the skin.

NCT ID: NCT00189293 Completed - Genital Warts Clinical Trials

Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts

Start date: June 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the recurrence rate following total clearance of external genital warts (EGWs) when clearance has been obtained by imiquimod (3 applications per week for 4 weeks) followed by ablative therapy (laser or electrocautery therapy) with that from just ablative therapy treatment alone.

NCT ID: NCT00092521 Completed - Cervical Cancer Clinical Trials

Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)

Start date: December 2001
Phase: Phase 3
Study type: Interventional

The primary purpose of the study is to determine if GARDASIL (V501) with four components is able to prevent cervical cancer, cervical dysplasia, including Cervical Intraepithelial Neoplasia (CIN)(Any Grade) and Adenocarcinoma In Situ (AIS), and genital warts.

NCT ID: NCT00092495 Completed - Cervical Cancer Clinical Trials

Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)

Start date: December 2002
Phase: Phase 3
Study type: Interventional

The primary purpose of the study is to determine if an investigational vaccine Gardasil (V501) with 4 components will provide an immune response and will be well tolerated in pre-adolescents and adolescents.

NCT ID: NCT00092482 Completed - Cervical Cancer Clinical Trials

Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)

Start date: June 28, 2002
Phase: Phase 3
Study type: Interventional

The purpose of the study is to determine if an investigational vaccine with a single component develops an immune response that is similar to the equivalent investigational vaccine with four components to reduce cervical disease.